Clinical and Metabolic Characteristics among Mexican Children with Different Types of Diabetes Mellitus

María Lola Evia-Viscarra, Rodolfo Guardado-Mendoza, Edel Rafael Rodea-Montero, María Lola Evia-Viscarra, Rodolfo Guardado-Mendoza, Edel Rafael Rodea-Montero

Abstract

Background: Current classification of diabetes mellitus (DM) is based on etiology and includes type 1 (T1DM), type 2 (T2DM), gestational, and other. Clinical and pathophysiological characteristics of T1DM and T2DM in the same patient have been designated as type 1.5 DM (T1.5DM).

Objectives: The aim of this study was to classify pediatric patients with DM based on pancreatic autoimmunity and the presence or absence of overweight/obesity, and to compare the clinical, anthropometric, and biochemical characteristics between children in the different classes of DM.

Methods: A sample of 185 patients, recruited (March 2008-April 2015) as part of the Cohort of Mexican Children with DM (CMC-DM); ClinicalTrials.gov, identifier: NCT02722655. The DM classification was made considering pancreatic autoimmunity (via antibodies GAD-65, IAA, and AICA) and the presence or absence of overweight/obesity. Clinical, anthropometric and biochemical variables, grouped by type of DM were compared (Kruskal-Wallis or chi-squared test).

Results: The final analysis included 140 children; 18.57% T1ADM, 46.43% T1BDM, 12.14% T1.5DM, and 22.86% T2DM. Fasting C-Peptide (FCP), and hs-CRP levels were higher in T1.5DM and T2DM, and the greatest levels were observed in T1.5DM (p<0.001 and 0.024 respectively).

Conclusions: We clearly identified that the etiologic mechanisms of T1DM and T2DM are not mutually exclusive, and we detailed why FCP levels are not critical for the classification system of DM in children. The findings of this study suggest that T1.5DM should be considered during the classification of pediatric DM and might facilitate more tailored approaches to treatment, clinical care and follow-up.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Classification system of diabetes mellitus…
Fig 1. Classification system of diabetes mellitus in pediatric patients.

References

    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37: 81–90. 10.2337/dc13-1041
    1. American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 2016;39: S13–S22. 10.2337/dc16-S005
    1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. Elsevier Ltd; 2014;383: 69–82. 10.1016/S0140-6736(13)60591-7
    1. Ziegler AG, Nepom GT. Prediction and Pathogenesis in Type 1 Diabetes. Immunity. Elsevier Inc.; 2010;32: 468–478.
    1. Umpaichitra V, Bastian W, Taha D, Banerji M a, AvRuskin TW, Castells S. C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2001;86: 1605–1609. 10.1210/jcem.86.4.7415
    1. Copeland KC, Silverstein J, Moore KR, Prazar GE, Raymer T, Shiffman RN, et al. Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents. Pediatrics. 2013;131: 364–82. 10.1542/peds.2012-3494
    1. Libman IM, Becker DJ. Coexistence of type 1 and type 2 diabetes mellitus: “double” diabetes? Pediatr Diabetes. 2003;4: 110–3. 10.1034/j.1399-5448.2003.00012.x
    1. Donath MY, Ehses J a. Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it was. Pnas. 2006;103: 12217–12218. 10.1073/pnas.0605480103
    1. Pozzilli P, Guglielmi C, Pronina E, Petraikina E. Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pediatr Diabetes. 2007;8 Suppl 9: 88–95.
    1. Village EG. The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118: 1510–1518. 10.1542/peds.2006-0690
    1. Nor NS, Jalaludin M, Harun F. Misdiagnosis of type 1 diabetes mellitus. Int J Pediatr Endocrinol. BioMed Central Ltd; 2013;2013: P23.
    1. Libman IM, Pietropaolo M, Arslanian S, LaPorte R, Becker DJ. Pathogenesis of Insulin-Treated Diabetes in Black and White Children. Diabetes Care. 2003;26: 2876–2882.
    1. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care. 1999;22: 1655–9. Available:
    1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004;114.
    1. Klünder-Klünder M, Flores-Huerta S. Waist circumference values according to height percentiles: a proposal to evaluate abdominal obesity in Mexican children and adolescents between 6 and 16 years of age. Arch Med Res. 2011;42: 515–22. 10.1016/j.arcmed.2011.09.004
    1. The Diabetes Control and Complications Trial Research Group. Effect of Intensive Therapy on Residual β-Cell Function in Patients with Type 1 Diabetes in the Diabetes Control and Complications Trial.pdf. Ann Intern Med. 1998;128: 517–523.
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18: 499–502.
    1. Dabelea D, D’Agostino RB, Mason CC, West N, Hamman RF, Mayer-Davis EJ, et al. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia. 2011;54: 78–86. 10.1007/s00125-010-1911-9
    1. Dabelea D, Pihoker C, Talton JW, D’Agostino RB, Fujimoto W, Klingensmith GJ, et al. Etiological approach to characterization of diabetes type: The SEARCH for diabetes in youth study. Diabetes Care. 2011;34: 1628–1633. 10.2337/dc10-2324
    1. R Development Core Team. A language and environment, for statistical computing Found Stat Comput Vienna, Austria; Vienna, Austria; 2006;
    1. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2014;15 Suppl 2: 4–17.
    1. American Diabetes Association. Type 2 Diabetes in Children and Adolescents. Pediatrics. 2000;105: 671–680.
    1. Gutiérrez J, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L et al. Encuesta Nacional de Salud y Nutrición 2012.Resultados Nacionales. Cuernavaca, México.; 2012.
    1. Fowler SP, Puppala S, Arya R, Chittoor G, Farook VS, Schneider J, et al. Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: The SAFARI Study. Hum Genet. 2013;132: 1059–1071. 10.1007/s00439-013-1315-2
    1. Purushothaman R, Ramchandani N, Kazachkova I, Ten S. Prevalence and clinical features of type 1.5 diabetes mellitus in children. J Pediatr Endocrinol Metab. 2007;20: 981–987.
    1. Atkinson M a. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2: a007641 10.1101/cshperspect.a007641
    1. Zeidler A, Frasier SD, Penny R, Stein RB, Nicoloff JT. Pancreatic islet cell and thyroid antibodies, and islet cell function in diabetic patients of Mexican-American origin. J Clin Endocrinol Metab. 1982;54: 949–54. 10.1210/jcem-54-5-949
    1. Juusola M, Parkkola A, Härkönen T, Siljander H, Ilonen J, Åkerblom HK, et al. Positivity for Zinc Transporter 8 Autoantibodies at Diagnosis Is Subsequently Associated With Reduced β-Cell Function and Higher Exogenous Insulin Requirement in Children and Adolescents With Type 1 Diabetes. Diabetes Care. 2016;39: 118–21.
    1. Ludvigsson J, Carlsson A, Forsander G, Ivarsson S, Kockum I, Lernmark A, et al. C-peptide in the classification of diabetes in children and adolescents. Pediatr Diabetes. 2012;13: 45–50. 10.1111/j.1399-5448.2011.00807.x
    1. Gilliam LK, Brooks-Worrell BM, Palmer JP, Greenbaum CJ, Pihoker C. Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes. J Autoimmun. 2005;25: 244–250. 10.1016/j.jaut.2005.09.013
    1. Pettitt DJ, Talton J, Dabelea D, Divers J, Imperatore G, Lawrence JM, et al. Prevalence of diabetes in U.S. Youth in 2009: The SEARCH for diabetes in youth study. Diabetes Care. 2014;37: 402–408. 10.2337/dc13-1838
    1. Hathout EH, Thomas W, El-Shahawy M, Nahab F, Mace JW. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics. 2001;107: E102 Available:
    1. Umpaichitra V, Banerji MA, Castells S. Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2002;15 Suppl 1: 525–530.
    1. Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C. Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. J Clin Endocrinol Metab. 2004;89: 2222–7. 10.1210/jc.2003-031360
    1. Daneman D. Type 1 diabetes. Lancet. 2006;367: 847–58. 10.1016/S0140-6736(06)68341-4
    1. Redondo MJ, Rodriguez LM, Escalante M, Smith EO, Balasubramanyam A, Haymond MW. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes. 2013;14: 333–340. 10.1111/pedi.12022
    1. Oram RA, Jones AG, Besser REJ, Knight BA, Shields BM, Brown RJ, et al. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia. 2014;57: 187–91. 10.1007/s00125-013-3067-x
    1. Wilkin TJ. The accelerator hypothesis: Weight gain as the missing link between Type I and Type II diabetes. Diabetologia. 2001;44: 914–922. 10.1007/s001250100548
    1. Knerr I, Wolf J, Reinehr T, Stachow R, Grabert M, Schober E, et al. The “accelerator hypothesis”: Relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia. 2005;48: 2501–2504. 10.1007/s00125-005-0033-2
    1. Lohmann T, Nietzschmann U, Kiess W. “Lady-like”: is there a latent autoimmune diabetes in the young? Diabetes Care. 2000;23: 1707–8. Available:

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅